Song Wu

"Vice director of Shenzhen Luohu Hospital Group(the Fifth People's Hospital of Shenzhen, The Affiliated Luohu Hospital of Shenzhen University),the president of Shenzhen Following Precision Medical Research Institute, M.D., Distinguished Research Fellow, standing vice director of National and local joint key technologies for tumor genomics and clinical application engineering laboratory. Mainly engaged in Urinary system tumor genomics and clinical precision medical research, published in Top international journal Nature genetics, European Urology, Cell research etc 28 achievements as first author or Communication author, total impact factor more over 201. European Urology, Annals of Oncology, Journal of Urology, Urologic Oncology, Journal of Experimental &Clinical Cancer Research and BMC Cancer reviewers, editorial member in Telomere and Telomerease.
Presided over the national natural foundation 1, Shenzhen major technology development projects 1, basic research projects 1, participating in 863, 973 program, Shenzhen technology research 1. 16 patent applications, 3 PCT, 3 invention patents have been approved .
Currently occupy a position as oncology group deputy team leader in Urinary Surgery Branch of Guangdong Medical Association, vice president of Guangdong Urological and Reproductive association, youth committee of Guangdong Anti-Cancer Association Professional Committee of Urological and Reproductive Tumors. Two second class prize for Chinese Medical Science in 2014, scientific Chinese Outstanding Young Scientist Award in 2015.
"